Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on December 10, 2020. The report details corporate governance amendments approved by the Board of Directors on the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the amendment and restatement of the Company's By-Laws. Key modifications include:
- Proxy Access: Implementation of provisions allowing a stockholder or group of up to 20 stockholders owning 3% or more of outstanding Class A common stock for at least three years to nominate director candidates.
- Nomination Limits: Eligible stockholders may nominate up to the greater of two directors or 20% of the Board.
- Voting Standard: Adoption of a plurality voting standard for director elections when the number of nominees exceeds the number of directors to be elected, replacing the previous majority voting standard.
- Conforming Changes: Removal of obsolete provisions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors. The document serves solely to disclose the By-Law amendments.
Key Facts for Investor Verification
- Verify the full text of the Amended and Restated By-Laws in Exhibit 3.1 to understand specific eligibility requirements for proxy access.
- Confirm the impact of the shift from majority to plurality voting on director election outcomes.
- Review subsequent filings for financial performance data, as this 8-K contains no financial metrics.